Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.41 - $33.99 $197,417 - $465,663
13,700 Added 37.23%
50,500 $1.58 Million
Q2 2024

Aug 15, 2024

SELL
$7.56 - $16.15 $295,596 - $631,465
-39,100 Reduced 51.52%
36,800 $571,000
Q1 2024

May 07, 2024

BUY
$7.96 - $12.37 $461,680 - $717,460
58,000 Added 324.02%
75,900 $803,000
Q4 2023

Feb 14, 2024

BUY
$4.9 - $12.86 $87,710 - $230,194
17,900 New
17,900 $214,000
Q2 2023

Aug 11, 2023

SELL
$7.61 - $9.46 $109,584 - $136,224
-14,400 Reduced 58.54%
10,200 $86,000
Q1 2023

May 16, 2023

BUY
$8.83 - $17.61 $217,218 - $433,206
24,600 New
24,600 $224,000
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $134,904 - $221,676
-8,400 Reduced 37.5%
14,000 $238,000
Q2 2022

Aug 15, 2022

SELL
$20.49 - $39.72 $530,691 - $1.03 Million
-25,900 Reduced 53.62%
22,400 $481,000
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $214,244 - $354,160
7,600 Added 18.67%
48,300 $1.79 Million
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $45,320 - $80,960
-1,100 Reduced 2.63%
40,700 $1.85 Million
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $11.5 Million - $17.8 Million
-193,800 Reduced 82.26%
41,800 $2.65 Million
Q2 2021

Aug 11, 2021

BUY
$63.02 - $95.11 $8.76 Million - $13.2 Million
139,000 Added 143.89%
235,600 $21.6 Million
Q1 2021

May 17, 2021

BUY
$57.62 - $95.6 $1.55 Million - $2.57 Million
26,900 Added 38.59%
96,600 $6.58 Million
Q4 2020

Feb 16, 2021

SELL
$41.43 - $77.09 $2.48 Million - $4.61 Million
-59,800 Reduced 46.18%
69,700 $5.05 Million
Q3 2020

Nov 16, 2020

BUY
$30.88 - $37.94 $852,288 - $1.05 Million
27,600 Added 27.09%
129,500 $4.91 Million
Q2 2020

Aug 14, 2020

BUY
$18.95 - $35.43 $805,375 - $1.51 Million
42,500 Added 71.55%
101,900 $3.61 Million
Q1 2020

May 15, 2020

BUY
$13.94 - $28.25 $394,502 - $799,475
28,300 Added 91.0%
59,400 $1.3 Million
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $340,548 - $502,857
-17,700 Reduced 36.27%
31,100 $671,000
Q3 2019

Nov 14, 2019

SELL
$20.03 - $40.08 $2.31 Million - $4.62 Million
-115,200 Reduced 70.24%
48,800 $1.1 Million
Q2 2019

Aug 14, 2019

SELL
$25.78 - $39.77 $528,490 - $815,285
-20,500 Reduced 11.11%
164,000 $5.9 Million
Q1 2019

May 15, 2019

BUY
$22.09 - $39.21 $3.05 Million - $5.42 Million
138,200 Added 298.49%
184,500 $5.82 Million
Q4 2018

Feb 14, 2019

BUY
$19.89 - $30.02 $198,900 - $300,200
10,000 Added 27.55%
46,300 $1.16 Million
Q3 2018

Nov 14, 2018

BUY
$12.1 - $28.85 $439,230 - $1.05 Million
36,300 New
36,300 $1.05 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.21B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.